Pseudomonas aeruginosa (Schroeter) Migula 拉丁名
(ATCC? 9027?) 編號
Strain Designations 菌株別名 R. Hugh 813
Application 用途 Assay of antimicrobial preservatives
Efficacy testing Media testing
Preparatory test control
Quality control strain
Sterility testing
Produces rhamnolipid surfactant
Pharmaceutical and Personal Care
Isolation 分離源 Outer ear infection
Biosafety Level 生物安全等級 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Storage Conditions 培養(yǎng)條件
Frozen 冷凍物 : -80°C or colder
Freeze-Dried 凍干粉 : 2°C to 8°C
Live Culture 活菌 : See Propagation Section
Preceptrol? no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC? Medium 3: Nutrient agar or nutrient broth
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 37°C
Atmosphere 需氧情況 : Aerobic
Name of Depositor 寄存人 CP Hegarty
Isolation 分離源 Outer ear infection
References 參考文獻 ckASTM International Standard Test Method for Preservatives in Water-Containing Cosmetics. West Conshohocken, PA
Zhang Y, Miller RM. Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant). Appl. Environ. Microbiol. 58: 3276-3282, 1992. PubMed: 1444363
British Pharmacopoeia Commission Test for sterility. London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XVI A, 2003
British Pharmacopoeia Commission Efficacy of antimicrobial preservation. London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XVI C, 2003
European Pharmacopoeia Commission Microbial contamination of products not required to comply with the test for sterility (tests for specified micro-organisms). Nutritive and selective properties of the media and validity of the test for specified micro-organisms. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.6.13, 1997
European Pharmacopoeia Commission Efficacy of antimicrobial preservation. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 5.1.3, 1997
U.S. Pharmacopeia General Chapters:ANTIMICROBIAL EFFECTIVENESS TESTING. Rockville, MD:U.S. Pharmacopeia;USP USP34-NF29, 2011 U.S.
Pharmacopeia General Chapters:STERILITY TESTS. Rockville, MD:U.S. Pharmacopeia;USP USP34-NF29, 2011
Jones CB, Platt JH. Propofol composition containing edetate. US Patent 5,714,520 dated Feb 3 1998
Efficacy of Preservation on Non-Eye Area Water-Miscible Cosmetic and Toiletry Formaulations. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 998.10.
Microbial limit test. Tokyo, Japan:Japanese Pharmacopoeia;JP Jp14e.part I.35.
Sterility test, Growth promotion test. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.54.
Preservatives-effectiveness test. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part II.12.
Ophthalmic optics--Contact lens care products--Microbiological requirements and test methods for products and regimens for hygienic management of contact lenses. Geneva (Switzerland):International Organization for Standardization/ANSI;ISO ISO 14729:2001.
Applied Biosystems, MicroSeq PHL Panel. Cosmetics - Microbiology - Detection of Pseudomonas aeruginosa. London, UK:British Standards Institution;British Standard BS ISO 22717:2006. U.S. Pharmacopeia General Chapters:Microbial Examination of Nonsterile Products: Microbial Enumeration Tests. Rockville, MD USP34-NF29, 2011
ISO/CD 11133:2009, Annex E. Test microorganisms for commonly used culture media (giving information on the culture medium, culture conditions, test microorganisms, culture collection number of test organisms and the expected reactions)
